Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Total Debt (2023 - 2025)

AVITA Medical filings provide 3 years of Total Debt readings, the most recent being $43.0 million for Q4 2025.

  • On a quarterly basis, Total Debt rose 1.75% to $43.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $43.0 million, a 1.75% increase, with the full-year FY2025 number at $43.0 million, up 1.75% from a year prior.
  • Total Debt hit $43.0 million in Q4 2025 for AVITA Medical, up from $42.4 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $45.2 million in Q2 2025 to a low of $39.8 million in Q4 2023.
  • Median Total Debt over the past 3 years was $42.4 million (2025), compared with a mean of $42.4 million.
  • The widest YoY moves for Total Debt: up 10.31% in 2025, down 0.23% in 2025.
  • AVITA Medical's Total Debt stood at $39.8 million in 2023, then grew by 6.11% to $42.2 million in 2024, then grew by 1.75% to $43.0 million in 2025.
  • The last three reported values for Total Debt were $43.0 million (Q4 2025), $42.4 million (Q3 2025), and $45.2 million (Q2 2025) per Business Quant data.